等待開盤 08-15 09:30:00 美东时间
-0.260
-1.55%
今日重点评级关注:花旗:维持Apellis Pharmaceuticals"买入"评级,目标价从46美元升至52美元;BTIG:维持Strategy"买入"评级,目标价从620美元升至700美元
08-04 09:30
Nature’s Sunshine Products (NATR) has disclosed a new risk, in the Capital Mark...
08-02 14:02
Nature's Sunshine Products shares are trading higher after the company reported...
08-02 02:07
Natures Sunshine Products (NASDAQ:NATR) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.17 by 112.12 percent. This is a 400 percent increase over earnings of $0.07 per share
08-01 04:17
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
Nature’s Sunshine Products, Inc. will host a conference call on July 31, 2025, at 5:00 p.m. ET (3:00 p.m. MT) to discuss its Q2 2025 financial results. CEO Terrence Moorehead and CFO Shane Jones will host the call, followed by a Q&A session. The call will be accessible via toll-free and international dial-in numbers (conference ID: 14947) or live webcast accessible on the company’s website. A replay will be available starting at 8:00 p.m. ET on t...
07-17 20:05
An update from Nature’s Sunshine Products ( ($NATR) ) is now available. On June...
07-08 04:49
Fosun Pharma USA is selling up to 2,854,607 shares of common stock held in Nature’s Sunshine Products (NASDAQ:NATR) at a price of $12.00 per share. The offering is expected to close on June 27, 2025, ...
06-26 18:51
Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine" or the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the launch of an underwritten secondary
06-26 04:23
Nature's Sunshine Products announced an underwritten secondary public offering of up to 2,854,607 shares of common stock by Fosun Pharma USA, Inc. The company does not sell any shares and will not receive proceeds. Fosun Pharma covers underwriting costs and related expenses, while Nature's Sunshine bears registration costs. The company may repurchase up to $15 million of shares under its share repurchase program, funded by cash and credit facilit...
06-25 20:01